113 related articles for article (PubMed ID: 23996966)
1. Selectivity in bone targeting with multivalent dendritic polyanion dye conjugates.
Gröger D; Kerschnitzki M; Weinhart M; Reimann S; Schneider T; Kohl B; Wagermaier W; Schulze-Tanzil G; Fratzl P; Haag R
Adv Healthc Mater; 2014 Mar; 3(3):375-85. PubMed ID: 23996966
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of dendritic polyglycerol anions and their efficiency toward L-selectin inhibition.
Weinhart M; Gröger D; Enders S; Dernedde J; Haag R
Biomacromolecules; 2011 Jul; 12(7):2502-11. PubMed ID: 21598905
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of radio and dye labeled amino functionalized dendritic polyglycerol sulfates as multivalent anti-inflammatory compounds.
Gröger D; Paulus F; Licha K; Welker P; Weinhart M; Holzhausen C; Mundhenk L; Gruber AD; Abram U; Haag R
Bioconjug Chem; 2013 Sep; 24(9):1507-14. PubMed ID: 23924212
[TBL] [Abstract][Full Text] [Related]
4. The interaction of cationic polymers and their bisphosphonate derivatives with hydroxyapatite.
Zhang S; Wright JE; Ozber N; Uludağ H
Macromol Biosci; 2007 May; 7(5):656-70. PubMed ID: 17457941
[TBL] [Abstract][Full Text] [Related]
5. Imparting bone mineral affinity to osteogenic proteins through heparin-bisphosphonate conjugates.
Gittens SA; Bagnall K; Matyas JR; Löbenberg R; Uludag H
J Control Release; 2004 Aug; 98(2):255-68. PubMed ID: 15262417
[TBL] [Abstract][Full Text] [Related]
6. Bone targeting potential of bisphosphonate-targeted liposomes. Preparation, characterization and hydroxyapatite binding in vitro.
Hengst V; Oussoren C; Kissel T; Storm G
Int J Pharm; 2007 Mar; 331(2):224-7. PubMed ID: 17150316
[TBL] [Abstract][Full Text] [Related]
7. Bone-specific drug delivery systems: approaches via chemical modification of bone-seeking agents.
Hirabayashi H; Fujisaki J
Clin Pharmacokinet; 2003; 42(15):1319-30. PubMed ID: 14674786
[TBL] [Abstract][Full Text] [Related]
8. Fluorescence imaging with multifunctional polyglycerol sulfates: novel polymeric near-IR probes targeting inflammation.
Licha K; Welker P; Weinhart M; Wegner N; Kern S; Reichert S; Gemeinhardt I; Weissbach C; Ebert B; Haag R; Schirner M
Bioconjug Chem; 2011 Dec; 22(12):2453-60. PubMed ID: 22092336
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of water-soluble polymeric bone-targeted drug delivery systems.
Wang D; Miller S; Sima M; Kopecková P; Kopecek J
Bioconjug Chem; 2003; 14(5):853-9. PubMed ID: 13129387
[TBL] [Abstract][Full Text] [Related]
10. Bisphosphonate-derivatized liposomes to control drug release from collagen/hydroxyapatite scaffolds.
Wang G; Babadağli ME; Uludağ H
Mol Pharm; 2011 Aug; 8(4):1025-34. PubMed ID: 21557579
[TBL] [Abstract][Full Text] [Related]
11. Silica xerogels and hydroxyapatite nanocrystals for the local delivery of platinum-bisphosphonate complexes in the treatment of bone tumors: a mini-review.
Iafisco M; Margiotta N
J Inorg Biochem; 2012 Dec; 117():237-47. PubMed ID: 22824154
[TBL] [Abstract][Full Text] [Related]
12. Multistep targeted nano drug delivery system aiming at leukemic stem cells and minimal residual disease.
Shi Y; Su Z; Li S; Chen Y; Chen X; Xiao Y; Sun M; Ping Q; Zong L
Mol Pharm; 2013 Jun; 10(6):2479-89. PubMed ID: 23646913
[TBL] [Abstract][Full Text] [Related]
13. Structure-biocompatibility relationship of dendritic polyglycerol derivatives.
Khandare J; Mohr A; Calderón M; Welker P; Licha K; Haag R
Biomaterials; 2010 May; 31(15):4268-77. PubMed ID: 20206990
[TBL] [Abstract][Full Text] [Related]
14. Engineering of cell membranes with a bisphosphonate-containing polymer using ATRP synthesis for bone targeting.
D'Souza S; Murata H; Jose MV; Askarova S; Yantsen Y; Andersen JD; Edington CD; Clafshenkel WP; Koepsel RR; Russell AJ
Biomaterials; 2014 Nov; 35(35):9447-58. PubMed ID: 25150889
[TBL] [Abstract][Full Text] [Related]
15. Development of efficient acid cleavable multifunctional prodrugs derived from dendritic polyglycerol with a poly(ethylene glycol) shell.
Calderón M; Welker P; Licha K; Fichtner I; Graeser R; Haag R; Kratz F
J Control Release; 2011 May; 151(3):295-301. PubMed ID: 21256902
[TBL] [Abstract][Full Text] [Related]
16. Bisphosphonate conjugation to proteins as a means to impart bone affinity.
Uludag H; Kousinioris N; Gao T; Kantoci D
Biotechnol Prog; 2000; 16(2):258-67. PubMed ID: 10753453
[TBL] [Abstract][Full Text] [Related]
17. Biomimetic hydroxyapatite-containing composite nanofibrous substrates for bone tissue engineering.
Venugopal J; Prabhakaran MP; Zhang Y; Low S; Choon AT; Ramakrishna S
Philos Trans A Math Phys Eng Sci; 2010 Apr; 368(1917):2065-81. PubMed ID: 20308115
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and in vitro hydroxyapatite binding of peptides conjugated to calcium-binding moieties.
Murphy MB; Hartgerink JD; Goepferich A; Mikos AG
Biomacromolecules; 2007 Jul; 8(7):2237-43. PubMed ID: 17530891
[TBL] [Abstract][Full Text] [Related]
19. Dendritic polyglycerol anions for the selective targeting of native and inflamed articular cartilage.
Reimann S; Schneider T; Welker P; Neumann F; Licha K; Schulze-Tanzil G; Wagermaier W; Fratzl P; Haag R
J Mater Chem B; 2017 Jun; 5(24):4754-4767. PubMed ID: 32264318
[TBL] [Abstract][Full Text] [Related]
20. Bisphosphonate-modified biomaterials for drug delivery and bone tissue engineering.
Ossipov DA
Expert Opin Drug Deliv; 2015; 12(9):1443-58. PubMed ID: 25739860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
